Concepedia
Publication | Open Access
Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study
141
Citations
23
References
2014
Year
ClinicalTrials.gov: NCT00265083.
Page 1